Comparison of the Botulinum toxin type A with oral Tizanidine in the treatment of spasticity due to stroke
Not Applicable
- Conditions
- Spasticity due to cerebral stroke.Sequelae of cerebral infarction
- Registration Number
- IRCT2012112411563N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
(to have a history of cerebral stroke for at least 3 months ago; severity of spasticity more than 2 in Ashworth scale; to be older than 35 years old)
Exclusion criteria: (patients with impairment in level or content of consciousness; to have systemic disorders such as Diabetes, hyperthyroidism, electrolyte disorders, renal failure; to be older than 70 years old)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method imbs Spasticity. Timepoint: in the start of the study for all the patients, week 16 (for Tizanidine) and 3 months after the last injection (for Botulinum). Method of measurement: Based on Ashworth scale.;Limb functional improvement. Timepoint: in the start of the study for all the patients, week 16 (for Tizanidine) and 3 months after the last injection (for Botulinum). Method of measurement: Based on ARAT scale.
- Secondary Outcome Measures
Name Time Method